Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender

Novo Nordisk A/S1 site in 1 country3,000 target enrollmentAugust 10, 2023

ConditionsOverweight Obesity

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Overweight
Sponsor: Novo Nordisk A/S
Enrollment: 3000
Locations: 1
Primary Endpoint: Score on IWQOL-Lite validated
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this survey is to collect information for scientific research and to identify the impact of overweight and obesity on health-related quality of life.

Registry

clinicaltrials.gov

Start Date

August 10, 2023

End Date

October 5, 2023

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Novo Nordisk A/S

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
•Male or female, age above or equal to 18 years at the time of signing informed consent.
•Not currently pregnant
•Does not participate in intense fitness or body building program
•Weight loss not through illness or injury
•Lives in South Korea, Australia, or India
•BMI above or equal to 18 and associated weight class (Normal Weight or above) will be determined by a programmed calculation based on participant-reported height and weight.

Exclusion Criteria

•Previous participation in this study. Participation is defined as having given informed consent in this study
•Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
•Does not meet inclusion criteria.